Cerenome CNSY
NASDAQ CNSY
$1.68 +0.00 (+0.00%)
As of: Oct 21, 2026 · 11:39 AM EDT

Cerenome (CNSY) Current Debt (2025 - 2026)

Updated

Analysis

Cerenome (CNSY) Current Debt (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn -5.75 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn -
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn -
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn -
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 64.00 Mn
10 Cerenome 11.59 Mn -35.59 Mn - -672,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -672,000.00
Mar 31, 2026 -100,000.00
Mar 31, 2025 -3.29 Mn
API Access

Cerenome Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=CNSY&period=max&api_key=YOUR_API_KEY